We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 724

Washington Healthcare Update- 8 Oct, 2018
  • McGuireWoods Consulting LLC
  • USA
  • October 8 2018

D.C. obsessed with Supreme Court nomination; opioids legislation hits the president’s desk for signature; 340B continues to be of concern


Washington Healthcare Update - Sep 10, 2018
  • McGuireWoods Consulting LLC
  • USA
  • September 10 2018

H.R. 6690, the Fighting Fraud to Protect Care for Seniors Act, would create a three-year pilot project in which beneficiaries’ traditional Medicare


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • July 23 2018

This week’s “Capitol Hill Healthcare Update” includes the latest on a series of healthcare bills scheduled for House votes, including one to repeal


Washington Healthcare Update - Jul 16, 2018
  • McGuireWoods LLP
  • USA
  • July 16 2018

In a two-day markup, the House Ways and Means Committee cleared a number of measures related to health savings accounts and a measure that would


Washington Healthcare Update - Jun 18, 2018
  • McGuireWoods LLP
  • USA
  • June 18 2018

The House began its two-week vote-a-thon on opioid legislation. On June 12, the house passed 25 bills and continued to work on opioid legislation


FDA Issues First of Four Draft Guidances Related to Patient-Focused Drug Development
  • Cooley LLP
  • USA
  • June 12 2018

Today, the U.S. Food and Drug Administration (FDA) released guidance titled, Patient-Focused Drug Development: Collecting Comprehensive and


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • June 11 2018

The House this week will begin considering some of the 70 different opioid bills that have been approved by eight different committees, focusing on


HHS Releases RFI to Request Input on Drug Pricing Proposals Read more:
  • Holland & Knight LLP
  • USA
  • May 29 2018

On May 14, 2018, HHS issued a request for information (RFI) on the administration's "American Patients First" drug pricing policy blueprint. The RFI


Administration presents plans to lower drug prices
  • Hogan Lovells
  • USA
  • May 14 2018

On May 11, 2018, President Trump and Department of Health and Human Services (HHS) Secretary Alex Azar delivered highly anticipated speeches regarding


Washington Healthcare Update - May 14, 2018
  • McGuireWoods LLP
  • USA
  • May 14 2018

The House announced its rescission package following a “message” from the White House about what programs it wanted to cut. Initially, President Trump